APA (7th ed.) Citation

Jiang, M., Liu, L., Xiang, X., Liang, R., Qin, X., Zhao, J., & Wei, Q. (2021). An MSC bone‐homing compound, Rab001, increases bone mass and reduces the incidence of osteonecrosis in a glucocorticoid‐induced osteonecrosis mouse model. Clinical & Experimental Pharmacology & Physiology, 48(5), 770. https://doi.org/10.1111/1440-1681.13441

Chicago Style (17th ed.) Citation

Jiang, Min, Lixian Liu, Xuexiang Xiang, Runmin Liang, Xuelian Qin, Jinmin Zhao, and Qingjun Wei. "An MSC Bone‐homing Compound, Rab001, Increases Bone Mass and Reduces the Incidence of Osteonecrosis in a Glucocorticoid‐induced Osteonecrosis Mouse Model." Clinical & Experimental Pharmacology & Physiology 48, no. 5 (2021): 770. https://doi.org/10.1111/1440-1681.13441.

MLA (9th ed.) Citation

Jiang, Min, et al. "An MSC Bone‐homing Compound, Rab001, Increases Bone Mass and Reduces the Incidence of Osteonecrosis in a Glucocorticoid‐induced Osteonecrosis Mouse Model." Clinical & Experimental Pharmacology & Physiology, vol. 48, no. 5, 2021, p. 770, https://doi.org/10.1111/1440-1681.13441.